Search Results

FDA Approves Lilly's Alzheimer's Disease Drug.

• Authors : Myshko, Denise

Subjects: *INSURANCE; THERAPEUTIC use of monoclonal antibodies; ALZHEIMER'S diseaseUNITED States. Food & Drug Administration

• Source: Formulary Watch. 7/2/2024, p1-3. 3p. 1 Color Photograph.

Record details

HYBRIDOMAS: Why Combine Lymphocytes and Cancer Cells?

Subjects: MEDICAL sciences; CANCER cells; HYBRIDOMAS

• Source: OYLA Magazine. Apr2024, Issue 41, p14-17. 4p. 3 Color Photographs, 3 Diagrams.

Record details

FDA Approves Jemperli as Frontline Treatment for Advanced Endometrial Cancer.

Subjects: THERAPEUTIC use of monoclonal antibodies; DRUG approval; DISEASE progressionUNITED StatesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 8/1/2023, p1-2. 2p.

Record details

Monoclonal Antibodies: From Skepticism to Success.

• Authors : TRAN, LAURA

Subjects: MONOCLONAL antibodies; B cells; IMMUNOGLOBULIN producing cells

• Source: Scientist. Spring2024, Vol. 38 Issue 1, p61-64. 4p.

Record details

FDA Advisory Committee Supports Donanemab in Alzheimer's Disease.

• Authors : Myshko, Denise

Subjects: *GROUP decision making; *COMMITTEES; THERAPEUTIC use of monoclonal antibodiesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 6/11/2024, p1-1. 1p.

Record details

FDA Sets Date of Advisory Committee Meeting for Donanemab in Alzheimer's Disease.

Subjects: *MEETINGS; ALZHEIMER'S disease prevention; THERAPEUTIC use of monoclonal antibodiesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 5/7/2024, p2-2. 1p.

Record details

Biogen to Stop Selling Alzheimer's Drug Aduhelm.

• Authors : Myshko, Denise

Subjects: *PRODUCT recall; *SALES personnel; *PHARMACEUTICAL industryUNITED States. Food & Drug Administration

• Source: Formulary Watch. 2/1/2024, p1-1. 1p.

Record details

FDA Sets Date for First-in-Class Lung Cancer Therapy.

Subjects: *QUALITY assurance; THERAPEUTIC use of monoclonal antibodies; LUNG cancerUNITED States. Food & Drug Administration

• Source: Formulary Watch. 2/20/2024, p1-1. 1p.

Record details

Risk Factors for Psoriasis Flares: A Narrative Review

• Authors : Potestio, Luca; Lauletta, Giuseppe; Tommasino, Nello

• Source: Psoriasis: Targets and Therapy. May 31, 2024, Vol. 14, p39, 12 p.

Record details

Is complement therapy the path forward for geographic atrophy? The 2 most developed therapies for GA are C3 and C5 inhibitors.

• Authors : Kovach, Jaclyn L.¹

Subjects: *THERAPEUTIC use of monoclonal antibodies; *DISEASE progression; *RETINAL degeneration

• Source: Ophthalmology Times. Jul2023, Vol. 48 Issue 7, p18-22. 3p.

Record details